• CB-839 (Telaglenastat) Experimental Workflow Guide

  2026-08-21

  Learn how to deploy CB-839 (Telaglenastat) in glutaminase-focused cell assays, metabolic profiling, autophagy studies, and combination experiments. This guide connects practical assay design with PRMT5-linked glutamine metabolism findings while clearly separating established evidence from testable hypotheses.

• Sulfachloropyridazine and Cecal Omics in Coccidiosis

  2026-08-20

  The reference study applies 16S rRNA sequencing and LC-MS/MS metabolomics to define how ethanamizuril, Sulfachloropyridazine, and their combination affect the cecal ecosystem of chickens infected with Eimeria tenella. Its main contribution is to connect anticoccidial treatment with microbiota and metabolite trajectories, while showing that low-dose combination therapy produced limited additional microbiome, metabolic, or anticoccidial effects.

• Cyanin Chloride in Psoriasis Barrier Biology

  2026-08-20

  A 2024 study used a cytokine-induced HaCaT psoriasis model to show that cyanin chloride can reduce inflammatory gene expression, inhibit STAT3 phosphorylation, and restore epithelial barrier function. Its combined redox, macrophage, keratinocyte, TEER, and filaggrin workflow provides a useful framework for evaluating anti-inflammatory and barrier-regulatory activity while highlighting the need for careful compound identity control.

• PBS (Phosphate-Buffered Saline) Workflow Guide

  2026-08-19

  PBS (Phosphate-Buffered Saline), SKU K2818, provides a sterile, isotonic solution for cell washing, reagent dilution, and routine in vitro workflows that require controlled pH and osmolarity. It should not be used as a complete cell-culture medium, a universal assay buffer, or for diagnostic, clinical, or medical applications without separate validation.

• Cytochalasin D: A Causal Lens on Cell Uptake

  2026-08-19

  Cytochalasin D is an actin polymerization inhibitor that can turn nanoparticle uptake experiments into stronger causal tests. This article explains how to use cytoskeletal perturbation, ocular barrier models, and orthogonal readouts without confusing reduced internalization with generalized cellular injury.

• DAPI (hydrochloride): DNA Readouts in PDOs

  2026-08-18

  DAPI (hydrochloride) provides a practical DNA readout for pancreatic ductal organoids, but its greatest value depends on matching staining mode to the biological question. This guide connects minor-groove binding, organoid assay design, cell-cycle interpretation, and the findings of a recent high-efficiency PDO study.

• YAP-TEAD Super-Enhancers in Ectoderm Fate

  2026-08-17

  Wang et al. show that YAP-TEAD activity regulates the early establishment of super-enhancers during pluripotent stem cell differentiation toward surface ectoderm. By combining three-dimensional genomic analysis with locus-specific CRISPR-dCas9 perturbation and transcription-factor experiments, the study connects enhancer architecture to lineage commitment and epithelial regeneration research.

• Merimepodib (VX-497) for IMPDH Research

  2026-08-17

  Merimepodib (VX-497) connects guanine nucleotide depletion with practical cancer, immunology, and host-directed antiviral assays. This workflow-focused guide explains how to prepare the compound, confirm IMPDH-dependent effects, reproduce the PEDV research logic, and troubleshoot weak or inconsistent phenotypes.

• EPZ-6438 EZH2 Inhibitor Workflow Guide

  2026-08-16

  EPZ-6438 provides a selective pharmacological route to suppress EZH2-driven H3K27me3, enabling target-engagement, proliferation, and resistance studies across cancer models. This guide translates its biochemical profile into practical workflows and extends recent melanoma findings into time-resolved combination assays.

• ATS-9R and the Future of Adipose Gene Delivery

  2026-08-15

  A translational perspective on how ATS-9R combines Prohibitin-mediated endocytosis with nona-arginine cargo condensation to advance gene silencing in adipocytes, adipose tissue macrophages, obesity-associated inflammation research, and metabolic disease models.

• Baricitinib (LY3009104) for JAK-STAT Research

  2026-08-15

  Baricitinib (LY3009104) provides a practical perturbation tool for testing JAK1/2-dependent cytokine signaling alongside spatial proteomics. This article translates PD-L1–IL-6 findings in primary sclerosing cholangitis into cell-based, co-culture, and preclinical assay workflows with built-in optimization controls.

• P. aeruginosa C/T Resistance: PKPD Study

  2026-08-14

  Deroche and colleagues used engineered mutants, clinical isolates, sequential time-kill experiments, and semi-mechanistic PKPD modeling to separate immediate from adaptive ceftolozane-tazobactam resistance. The study shows that ampC and ampD mutations have distinct, time-dependent effects and that their combination can markedly reduce susceptibility while altering imipenem response.

• SHH, FGF10, and Species-Specific Penile Development

  2026-08-14

  A 2025 Cells study shows that species-specific differences in prepuce and urethral groove formation are associated with differential Shh, Fgf10, and Fgfr2 expression in developing genital tubercles. Comparative gene expression, tissue culture, and protein perturbation experiments provide a mechanistic framework for interpreting mouse models of human penile development and congenital malformation research.

• Caspase-3 Colorimetric Assay Kit in ER Stress

  2026-08-13

  The Caspase-3 Colorimetric Assay Kit provides a practical way to test whether ER stress and inflammatory activation culminate in executioner-caspase activity. This article connects K2008 assay design with the IgSF6 intestinal macrophage study while defining controls, interpretive limits, and complementary readouts.

• CCT007093: A Mechanism-First PPM1D Assay Guide

  2026-08-13

  Explore how CCT007093 functions as a PPM1D inhibitor and how to interpret its effects across p38 signaling, breast cancer, and renal injury models. This mechanism-first guide emphasizes assay design, controls, model selection, and the limits of translating pathway observations into target-specific conclusions.

448 records 7/30 page Previous Next First page 上5页 678910 下5页 Last page